Ligand Pharmaceuticals | LGND - 市值

金融业

USD

USD 1.53B

现金及等价物

USD 115.08M

USD 11.37M

USD 865.42M

USD 40.67M

USD 451.49M

USD 60.33M

USD 66.78M

68

EPS每股收益

USD 1.63

股本和储备

USD 997.32M

USD 48.45M

债务利息支出

USD 1.79M

USD 6.39M

USD 446.19M

USD 5.66B

USD -13.35M

USD 34.35M

USD 60.33M

普通股股本

USD 19.66M

56.5

USD 56.78M

USD 51.72M

销售和管理费用

USD 20.84M

USD 13.27M

贸易债权人

USD 37.11M

应收帐款人

USD 54.8M

	市值	更改		日
Amgen	USD 189.89B		13.64B	2026-03
Anika Therapeutics	USD 139M		3M	2025-12
Arrowhead Research	USD 8.78B		236M	2026-03
Baxter International	USD 8.67B		1.15B	2026-03
Bristol-Myers Squibb	USD 123.83B		14.02B	2026-03
Eli Lilly	USD 869.02B		146.97B	2026-03
Enanta Pharmaceuticals	USD 122M		98M	2024-12
Enviri Corporation	USD 1.45B		423M	2025-12
Gilead Sciences	USD 172.99B		20.71B	2026-03
GlaxoSmithKline	GBP 83.8B		9.44B	2026-03
Glaxosmithkline	GBP 108.55B		736M	2026-07
Heron Therapeutics	USD 238M		7M	2025-12
Insmed	USD 35.3B		1.82B	2026-03
Ionis Pharmaceuticals	USD 12.46B		356M	2026-03
Karyopharm Therapeutics	USD 1.12B		989M	2026-07
Ligand Pharmaceuticals	USD 3.98B		241M	2026-03
MacroGenics	USD 287M		103M	2026-07
Merck	USD 297.1B		35.84B	2026-03
Pacira	USD 915M		149M	2026-03
Pfizer	USD 153.81B		12.24B	2026-03
Veracyte	USD 2.57B		758M	2026-03